| Sector |
Plastic Products
|
Compare with Sector peers |
| Industry |
Plastic Products
|
Compare with Industry peers |
| Website | http://www.bilcare.com | |
| Market Cap | 101.67 Cr. | |
| Enterprise Value(EV) | 800.77 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -15.71 | Trailing Twelve Months Ending 2022-12 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
| Industry PE | 24.61 | Trailing Twelve Months Ending 2022-12 |
| Book Value / Share | 19.09 | Trailing Twelve Months Ending 2022-12 |
| Price to Book Value | 2.26 | Calculated using Price: 43.18 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 2.35 Cr. | 23,545,231 Shares |
| FaceValue | 10 | |
| About Bilcare Ltd. | ||
| Bilcare, incorporated in the year 1987, is engaged in manufacturing pharmaceutical packaging. It has an experience of working with 500 pharma manufacturing companies worldwide.Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. The company endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients. | ||
| 1 Day |
|
-0.90% |
| 1 Week |
|
-1.84% |
| 1 Month |
|
-4.64% |
| 3 Month |
|
-19.44% |
| 6 Month |
|
+18.95% |
| 1 Year |
|
-32.69% |
| 2 Year |
|
-24.51% |
| 5 Year |
|
-7.44% |
| 10 Year |
|
-42.50% |
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -9.38 | -14.86 | -9.09 | -12.03 | -39.29 | -274.69 | -515.03 | -11.48 | -5.40 | |
| Return on Capital Employed (%) | 3.36 | 1.16 | -1.40 | 4.40 | 1.64 | -6.38 | 4.01 | 6.41 | 8.46 | |
| Return on Assets (%) | -2.83 | -4.13 | -2.07 | -2.26 | -5.81 | -13.97 | -4.82 | -1.13 | -0.44 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 1,324 | 1,096 | 713 | 614 | 400 | -70 | 108 | 86 | 75 | 64 | |
| Non Curr. Liab. | 2,126 | 2,228 | 2,090 | 2,036 | 960 | 1,024 | 535 | 477 | 449 | 460 | |
| Curr. Liab. | 866 | 966 | 758 | 745 | 1,978 | 2,069 | 311 | 314 | 403 | 426 | |
| Minority Int. | 53 | 49 | 59 | 62 | 63 | 64 | 68 | 78 | 86 | 90 | |
| Equity & Liab. | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,023 | 955 | 1,013 | 1,040 | |
| Non Curr. Assets | 2,444 | 2,293 | 2,713 | 2,669 | 2,469 | 2,205 | 657 | 618 | 592 | 578 | |
| Curr. Assets | 1,924 | 2,047 | 907 | 788 | 933 | 882 | 365 | 337 | 421 | 462 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 4,368 | 4,340 | 3,620 | 3,457 | 3,402 | 3,087 | 1,023 | 955 | 1,013 | 1,040 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
| Net Sales | 3,062 | 2,692 | 2,603 | 2,633 | 2,778 | 2,997 | 1,827 | 623 | 845 | 1,004 | |
| Other Income | 18 | 46 | 30 | 39 | 34 | 60 | 97 | 18 | 15 | 15 | |
| Total Income | 3,080 | 2,738 | 2,633 | 2,672 | 2,813 | 3,057 | 1,924 | 641 | 859 | 1,019 | |
| Total Expenditure | -2,823 | -2,507 | -2,396 | -2,445 | -2,621 | -2,829 | -1,782 | -572 | -784 | -943 | |
| PBIDT | 257 | 231 | 237 | 227 | 192 | 229 | 142 | 69 | 75 | 76 | |
| Interest | -217 | -236 | -151 | -176 | -249 | -283 | -174 | -76 | -69 | -66 | |
| Depreciation | -141 | -191 | -164 | -177 | -416 | -378 | -239 | -46 | -39 | -38 | |
| Taxation | -23 | 16 | 112 | -24 | 8 | -21 | 15 | 14 | 0 | 0 | |
| Exceptional Items | -117 | 70 | 267 | 157 | 27 | 29 | -4 | ||||
| PAT | -124 | -180 | -82 | -80 | -199 | -453 | -99 | -11 | -4 | -32 | |
| Minority Interest | 1 | 0 | -3 | -5 | -2 | -2 | -5 | -10 | -8 | -5 | |
| Share Associate | |||||||||||
| Other Related Items | -2 | ||||||||||
| Consolidated Net Profit | -113 | -216 | -85 | -85 | -201 | -458 | -104 | -21 | -13 | -37 | |
| Adjusted EPS | -52 | -76 | -36 | -36 | -85 | -194 | -44 | -9 | -5 | -16 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 227 | 314 | -315 | 177 | 300 | 98 | 206 | 256 | 72 | 41 | |
| Cash Fr. Inv. | -966 | -351 | 247 | -358 | -129 | -203 | -104 | 1,309 | 2 | -4 | |
| Cash Fr. Finan. | 661 | 48 | 119 | 149 | -155 | 91 | -103 | -1,600 | -83 | -55 | |
| Net Change | -78 | 12 | 50 | -32 | 16 | -13 | -1 | -35 | -9 | -18 | |
| Cash & Cash Eqvt | 94 | 106 | 156 | 73 | 90 | 77 | 76 | 41 | 32 | 14 |
|
Wed, 24 May 2023
Board Meeting Intimation for Considering And Approving The Audited Financial Results For The Quarter & Year Ended March 31 2023 BILCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Notice is hereby given that the meeting of the Board of Directors of the Company is scheduled to be held on 30th May 2023 inter alia to consider and take on record the Audited Financial Result (Standalone & Consolidated) for the Quarter and Year ended 31st March 2023 |
|
Thu, 20 Apr 2023
Compliance Certificate Under Regulation 7(3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015. Compliance Certificate under Regulation 7(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015. |
|
Wed, 19 Apr 2023
Non-Applicability Of SEBI Circular-SEBI/HO/DDHS/CIR/P/2018/144Dated November 26 2018 With Respect To Fund Raising By Issuance Of Debt Securities By Large Entitie Non-applicability of SEBI Circular-SEBI/HO/DDHS/CIR/P/2018/144dated November 26 2018 with respect to Fund raising by issuance of Debt securities by Large Entitie |
| Fri, 26 May 2023 |
Opening at High
|
Close Below Last Month Low
|
High Decrease in 3 Months
|
High Decrease in 1 Year
|
CCI Oversold Zone
|
Equities
M.F.
Sectors
StockEdge Social